breast cancer
Conditions
Interventions
Exposure group:Use Chinese Patent Medicine
Control group:Not use Chinese Patent Medicine
Sponsors
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
40 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Female patients with breast cancer confirmed by histopathology and/or cytology; (2) Age = 40 years; (3) Patients currently receiving or having previously received standardized chemotherapy regimens, with reference to NCCN or NICE guidelines; (4) Chemotherapy may be combined with targeted therapy or endocrine therapy; (5) Patients with hospital admission records for at least two chemotherapy cycles during the study period.
Exclusion criteria
Exclusion criteria: (1) Patients who have undergone radiotherapy for breast cancer; (2) Patients with other primary malignancies; (3) Patients with severe cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic system diseases; patients deemed by investigators to have serious primary diseases making them ineligible for inclusion; patients with infectious or psychiatric disorders; (4) Patients with missing key information (key information includes: histopathological or cytological examination results, chemotherapy regimen, and Chinese patent medicine usage records).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse events in breast cancer patients after chemotherapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of nausea and vomiting;Incidence of decreased appetite;Incidence of diarrhea;Incidence of Anemia;Incidence of Thrombocytopenia;Incidence of Leukopenia;Incidence of Neutropenia;Incidence of Cardiac Dysfunction;Incidence of Myocardial Injury;Incidence of Abnormal Liver Function;Incidence of Abnormal Renal Function; | — |
Countries
China
Contacts
Public ContactYi Yuan
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine
Outcome results
None listed